Status:
COMPLETED
EXercise Training for the Prevention of Cancer Thrombosis (EXPECT) Pilot Trial
Lead Sponsor:
University of Vermont
Conditions:
Cancer Thrombosis
Eligibility:
All Genders
18-79 years
Phase:
NA
Brief Summary
Patients with lymphoma or cancer who are receiving chemotherapy in the outpatient setting are at risk for blood clots which form in the veins. The occurrence of blood clots has major implications on p...
Detailed Description
Activation of the blood coagulation system is a common manifestation in cancer associated with premature death from venous thromboembolism (VTE).(1-5) Ambulatory cancer patients undergoing chemotherap...
Eligibility Criteria
Inclusion
- Diagnosis of lymphoma or cancer
- Beginning chemotherapy regimen
- Patient self-report of ability to walk 10 minutes without interruption or pain
- Age \>18 and \<80
- Willingness to participate in the oncology rehabilitation program at Tilley Drive South Burlington
Exclusion
- Presence or history of DVT or PE prior to entry
- Antithrombotic therapy including warfarin, dabigatran, low molecular weight heparin or unfractionated heparin which will alter levels of hemostatic factors (Off Lovenox 48 hours before first study blood draw)
- Medical condition that alters ability to walk for exercise
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01853202
Start Date
March 1 2013
Last Update
December 4 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fletcher Allen Healthcare
Burlington, Vermont, United States, 05401